EUNATE
ARANA ARRI
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaInstituto de Investigación Sanitaria Biogipuzkoa-ko ikertzaileekin lankidetzan egindako argitalpenak (6)
2022
-
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340
-
Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study
eClinicalMedicine, Vol. 51
2019
-
Quality indicators and patient satisfaction in colonoscopy
Gastroenterologia y Hepatologia, Vol. 42, Núm. 2, pp. 73-81
2018
-
Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model
BMC Cancer, Vol. 18, Núm. 1
-
Screening colonoscopy and risk of adverse events among individuals undergoing fecal immunochemical testing in a population-based program: A nested case-control study
United European Gastroenterology Journal, Vol. 6, Núm. 5, pp. 755-764
2017
-
Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model
BMC Public Health, Vol. 18, Núm. 1